Acurian

Horsham, United States Founded: 1998 • Age: 28 yrs Acquired By PPD
Patient enrollment and retention solutions for clinical trials are offered.
Request Access

About Acurian

Acurian is a company based in Horsham (United States) founded in 1998 was acquired by PPD in August 2013.. Acurian has raised $27 million across 1 funding round from investors including Merck, J P Morgan and PPD. Acurian offers products and services including Patient Recruitment and Integrated Network. Acurian operates in a competitive market with competitors including Elligo, Velocity Clinical Research, CenExel, Wake Research and Inclinix, among others.

  • Headquarter Horsham, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Global Aes
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $27 M (USD)

    in 1 rounds

  • Latest Funding Round
    $27 M (USD), Series B

    Mar 27, 2001

  • Investors
    Merck

    & 4 more

  • Employee Count
    Employee Count
  • Acquired by
    PPD

    (Aug 27, 2013)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Acurian

Acurian offers a comprehensive portfolio of products and services, including Patient Recruitment and Integrated Network. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Data-driven strategy for recruiting patients in clinical trials

Manages sites and patients for efficient trial performance

Funding Insights of Acurian

Acurian has successfully raised a total of $27M through 1 strategic funding round. The most recent funding activity was a Series B round of $27 million completed in March 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series B — $27.0M
  • First Round

    (27 Mar 2001)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2001 Amount Series B - Acurian Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Acurian

Acurian has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Merck, J P Morgan and PPD. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investment strategies are provided across diverse asset classes and markets.
Founded Year Domain Location
-
Founded Year Domain Location
Pharmaceutical products are manufactured and marketed worldwide.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Acurian

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Acurian

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Acurian Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Acurian

Acurian operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Elligo, Velocity Clinical Research, CenExel, Wake Research and Inclinix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Patient recruitment and site activation services are provided by Elligo.
domain founded_year HQ Location
Provider of site management and patient recruitment services
domain founded_year HQ Location
Research site management and patient recruitment services are provided.
domain founded_year HQ Location
Clinical site management, patient recruitment, and retention services are provided.
domain founded_year HQ Location
Customized solutions for clinical trial enrollment are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Acurian

Frequently Asked Questions about Acurian

When was Acurian founded?

Acurian was founded in 1998 and raised its 1st funding round 3 years after it was founded.

Where is Acurian located?

Acurian is headquartered in Horsham, United States. It is registered at Horsham, Pennsylvania, United States.

Is Acurian a funded company?

Acurian is a funded company, having raised a total of $27M across 1 funding round to date. The company's 1st funding round was a Series B of $27M, raised on Mar 27, 2001.

What does Acurian do?

Founded in 1998 and based in Horsham, United States, Acurian operates as a subsidiary of PPD within the clinical research sector. Services focus on patient enrollment and retention for trials, utilizing a database of over 100 million opted-in individuals alongside various recruitment methods. Customized plans are developed to target specific therapeutic areas, supporting faster trial timelines and results-based pricing models.

Who are the top competitors of Acurian?

Acurian's top competitors include Velocity Clinical Research, Elligo and CenExel.

What products or services does Acurian offer?

Acurian offers Patient Recruitment and Integrated Network.

Who are Acurian's investors?

Acurian has 5 investors. Key investors include Merck, J P Morgan, PPD, Caisse de depot et placement du Quebec, and ProQuest Investments.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available